This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Buccal lichen planus

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A white asymptomatic fine streaking, particularly of the buccal mucosa, is found in 50% of patients with lichen planus.

All age groups can be affected (usually the onset occurs in the fifth or sixth decade) (1). It can present in several forms:

  • atrophic }
  • bullous } can cause mild to severe pain
  • erosive }
  • papular
  • pigmented
  • plaquelike
  • reticular - most common form, usually asymptomatic - typical clinical features are represented by bilaterally located white papules that enlarge and coalesce to form reticulations, the so-called Wickham's striae

Oral lichen planus is a chronic disorder of the oral cavity that rarely undergoes spontaneous remission (5)

  • affects approximately 1% to 2% of the population, mainly middle-aged adults
  • women are slightly more likely than men to have this condition
  • commonly affected sites are the buccal mucosa bilaterally, the borders and dorsum of the tongue, and the gingiva
    • palate (either hard or soft), the lips and the floor of the mouth are rarely involved
  • has a fluctuating course with apparent spontaneous exacerbations and improvements in disease activity within an individual patient
  • people with OLP have an increased risk of developing oral squamous cell carcinoma (SCC)

Clinical appearance alone, particularly when showing the "classic" reticular form, may sometimes allow a definitive diagnosis

  • biopsy of suspected oral lichen planus is prudent clinical practice
    • histopathology can be subjective and non-specific - however it can be useful to exclude dysplasia and SCC
    • when exclusive gingival or predominantly erosive or ulcerative lesions are present, immunological tests are warranted to achieve a proper diagnosis (4)

Oral lesions are more difficult to manage:

Troublesome oral symptoms can be treated as follows (3):

  • Topical analgesia is available as a mouthwash and spray eg Difflam ®
  • A number of topical anti-inflammatories can be used as a gargle for 2-4 minutes, 3-4 times a day
    • Betamethasone 500 microgram soluble tablet dissolved in 10 ml of water
    • Flixonase ® Nasule ® drop 400 micrograms dissolved in 10 ml of water
    • Doxycycline 100 mg dispersible tablets have both anti-inflammatory and antibacterial properties
  • there are various methods of delivering topical steroids to the oral mucosa (e.g. lozenges, pastes) but responses are often indifferent and secondary candida infection is all too common (1,2)
  • there is data that suggest that tacrolimus or pimecrolimus may have a role in the management of oral lichen planus (1)
  • in patients with chronic oral lichen planus then these patients should be kept under surveillance for the development of oral cancer (1)
  • very low-certainty evidence suggests that calcineurin inhibitors, specifically tacrolimus, may be more effective at resolving pain than corticosteroids (5)

Reference:

  1. Dermatology in Practice 2004; 12 (2): 25-6.
  2. Usatine R, Tinitigan M. Diagnosis and Treatment of Lichen Planus. American Family Physician. 2011 Jul1;84 (1):53-60.
  3. Primary Care Dermatological Society. Lichen planus (Accessed 2/9/2020)
  4. Dorothea C et al. Oral lichen planus. Arch Dermatol. 2007;143(4):511-515
  5. Lodi G et al. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Systematic Review;28 February 2020

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.